Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Multiple Myeloma 69Lymphoma 20Lymphoma, Mantle-Cell 19Leukemia, Myeloid, Acute 17Leukemia, Lymphocytic, Chronic, B-Cell 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Non-Hodgkin 15Neoplasms, Plasma Cell 14Lymphoma, Large B-Cell, Diffuse 14Lymphoma, Follicular 13Lymphoma, B-Cell, Marginal Zone 12Unspecified Adult Solid Tumor, Protocol Specific 10Hodgkin Disease 10Lymphoma, Large-Cell, Anaplastic 9Immunoblastic Lymphadenopathy 9Waldenstrom Macroglobulinemia 8Recurrence 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia 8Burkitt Lymphoma 8Myelodysplastic Syndromes 7Lymphoma, T-Cell, Cutaneous 7Head and Neck Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Sezary Syndrome 6Neoplasms 6Mycosis Fungoides 6Lymphoma, Large-Cell, Immunoblastic 6Congenital Abnormalities 6Breast Neoplasms 6

Interventions

Paclitaxel 12Gemcitabine 9atezolizumab 8Carboplatin 8Bevacizumab 6tocilizumab 4navitoclax 4liposomal doxorubicin 4Irinotecan 4Erlotinib Hydrochloride 4Cetuximab 4Sunitinib 3Oxaliplatin 3Leucovorin 3Injections 3Fluorouracil 3Docetaxel 3Cyclophosphamide 3tumor necrosis factor-alpha, CNGRC fusion protein, human 2tislelizumab 2temsirolimus 2ridaforolimus 2plocabulin 2pembrolizumab 2pazopanib 2olaparib 2obinutuzumab 2linifanib 2fludarabine 2envafolimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Solid Tumors × Bortezomib × Clear all
NCT00720148 2014-08-26

A Phase I Trial of Bortezomib and Sunitinib

Emory University

Phase 1 Completed
30 enrolled
Other solid neoplasm

Solid Tumors

NCT00500422 2013-02-13

Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Completed
134 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡